Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net loss	$ (21,501)	$ (38,688)	$ (33,245)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	4,687	3,494	1,238
Operating lease right-of-use assets expense	6,234	5,945	0
Foreign currency remeasurement loss	0	835	1,308
Stock-based compensation	36,048	37,218	59,508
Deferred income taxes	(864)	3,701	(175)
Other	1,068	(607)	(755)
Change in value of earn-out and warrant liabilities	11,454	(4,402)	(21,233)
Changes in operating assets and liabilities:
Accounts receivable	(19,448)	(14,388)	(8,243)
Prepaid expenses and other current assets	(2,773)	(2,108)	(5,914)
Deferred contract costs and other assets	(7,687)	(9,596)	(8,890)
Accounts payable, accrued expenses, operating lease liabilities and other liabilities	609	(2,553)	10,626
Deferred revenue	26,867	20,375	10,805
Net cash provided by (used in) operating activities	34,694	(774)	5,030
Investing activities
Maturities of investments	2,620	183,554	0
Purchases of investments	(3,497)	(180,969)	(916)
Cash paid in business combinations and asset acquisitions, net of cash acquired	0	(18,572)	0
Capitalization of internal-use software	(1,434)	(1,612)	0
Purchase of property and equipment	(2,087)	(3,853)	(2,461)
Investment in notes	(1,250)	0	0
Net cash used in investing activities	(5,648)	(21,452)	(3,377)
Financing activities
Proceeds from recapitalization of Apex shares, net of transaction fees of $49,990	0	0	441,573
Redemption of redeemable convertible preferred stock	0	0	(130,925)
Redemption of Legacy AvePoint common stock	0	0	(106,169)
Purchase of common stock	(39,036)	(19,927)	(1,628)
Payment of net cash settlement for management options	0	0	(7,530)
Proceeds from stock option exercises	5,569	2,818	5,566
Proceeds from sale of common shares of subsidiary	0	0	753
Repayments of finance leases	(64)	(39)	(25)
Payments of debt issuance costs	(136)	0	0
Payments of transaction fees by Legacy AvePoint	0	0	(2,998)
Net cash (used in) provided by financing activities	(33,667)	(17,148)	198,617
Effect of exchange rates on cash	595	(1,655)	(1,165)
Net (decrease) increase in cash and cash equivalents	(4,026)	(41,029)	199,105
Cash and cash equivalents at beginning of period	227,188	268,217	69,112
Cash and cash equivalents at end of period	223,162	227,188	268,217
Supplemental disclosures of cash flow information
Income taxes paid	6,112	3,320	4,037
Contingent considerations in business combination	0	5,635	0
Common stock issued in business combination	0	1,517	0
Loan to certain acquiree shareholders	$ 0	$ 235	$ 0